Literature DB >> 21957341

Mutational spectrum of thalassemias in India.

Inusha Panigrahi1, R K Marwaha.   

Abstract

Entities:  

Year:  2007        PMID: 21957341      PMCID: PMC3168153          DOI: 10.4103/0971-6866.32034

Source DB:  PubMed          Journal:  Indian J Hum Genet        ISSN: 1998-362X


× No keyword cloud information.
Sir, Thalassemias are common genetic disorders in the Indian subcontinent.[1] Thalassemia major is the severe phenotype which requires lifelong transfusions and bone marrow transplantation is the only curative option available. Knowledge of the ethnic and geographic origin would enable molecular analysis to be tailored, keeping in view the specific mutations in that community or area. The following write-up gives a concise representation of the common thalassemia mutations in Indians. Beta-thalassemia is clinically more significant in India, with higher incidence in certain communities. Few common mutations account for >95% of severe beta-thalassemia cases. Concurrent presence of alpha thalassemia modifies the phenotype of beta-thalassemia. Alpha-thalassemia is not a significant problem in India because the severe alpha deletion mutations are less common in this region. The carrier rate for β-thalassemia varies from 3-17%.[1] The alpha thalassemia carrier rate in India varies from 1 to 80%.[1] But it is clinically less significant than β-thalassemia. Alpha thalassemia if present in β-homozygous thalassemia patients ameliorates the phenotype and majority present as thalassemia intermedia.[23] Hb E (hemoglobin E) is abnormal hemoglobin prevalent in North-Eastern States.[4] The five common mutations -IVS 1-5 G → C, IVS 1 -1 G → T, Codon 41/42 (- TCTT), Codon 8/9 and the 619 bp deletion account for over 90% of the mutations in b-thalassemia patients.[56] The mutations reported from different regions of India are listed in Figure 1.[7-12] IVS-I-5 (G → C) is the most common beta-thalassemia allele in the Indian population. Sindhis and Lohanas especially from Gujarat show high prevalence of the 619 bp deletion mutation. Rare beta-thalassemia mutations were found in 87/1233(7.06%) carriers.[8] High frequency of the IVS-1-1 (G →T) mutation was also found in Sindhis (25.5%), Punjabi Hindus (34.7%) and Lohanas (31.2%) in the study. Jat Sikhs, a subcaste of Punjabis, revealed a very high prevalence (46%: 41/88) of the mild β++ promoter mutation -88 (C-T) in a recent study.[13] Un-transfused patients had characteristically high Hb F (38.1-68.6%, mean 47.4%) and also Hb A2 (5.7-9.8%, mean 6.88%) values.
Figure 1

The pie charts depict the prevalence of ten common mutations in β-thalassemia cases in different regions of India. The keys are given as shaded rectangles

The pie charts depict the prevalence of ten common mutations in β-thalassemia cases in different regions of India. The keys are given as shaded rectangles In alpha thalassemia the common mutations are - α3.7, - α4.2, -SA(South African deletion)[14] and Hb Constant Spring. The commonest mutation is - α3.7 deletion. Hb Koya Dora is found at high frequency (10%) in certain communities of Andhra Pradesh.[15] Hb Constant Spring and Hb Koya Dora are termination codon mutations leading to an elongated alpha chain. The α0 alleles (double deletion on one chromosome involving 2 alpha genes) are less common in India compared to neighboring South East Asian Countries like China and Taiwan. This is one of the reasons for alpha-thalassemia being a less important problem. To conclude, knowledge of the native origin of affected families can help in identifying the common possible mutations and accordingly molecular analysis can be phased out.
  14 in total

1.  The molecular basis of thalassaemia major and thalassaemia intermedia in Asian Indians: application to prenatal diagnosis.

Authors:  S L Thein; C Hesketh; R B Wallace; D J Weatherall
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

2.  Regional distribution of beta-thalassemia mutations in India.

Authors:  I C Verma; R Saxena; E Thomas; P K Jain
Journal:  Hum Genet       Date:  1997-07       Impact factor: 4.132

3.  Beta-thalassaemia mutations in northern India (Delhi).

Authors:  N Madan; S Sharma; U Rusia; S Sen; S K Sood
Journal:  Indian J Med Res       Date:  1998-03       Impact factor: 2.375

4.  Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.

Authors:  Gurjeewan Garewal; Reena Das; Jasmina Ahluwalia; R K Marwaha; S Varma
Journal:  Am J Hematol       Date:  2005-08       Impact factor: 10.047

5.  Molecular pathogenesis and clinical variability of beta-thalassemia syndromes among Indians.

Authors:  A Nadkarni; A C Gorakshakar; C Y Lu; R Krishnamoorthy; K Ghosh; R Colah; D Mohanty
Journal:  Am J Hematol       Date:  2001-10       Impact factor: 10.047

6.  Characterization of beta-thalassaemia mutations in 57 beta-thalassaemia families seen at Lucknow.

Authors:  S Agarwal; M Naveed; U R Gupta; P Kishore; S S Agarwal
Journal:  Indian J Med Res       Date:  1994-09       Impact factor: 2.375

7.  The molecular basis of beta thalassaemia in Punjabi and Maharashtran Indians includes a multilocus aetiology involving triplicated alpha-globin loci.

Authors:  G Garewal; C W Fearon; T C Warren; N Marwaha; R K Marwaha; C Mahadik; H H Kazazian
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

8.  Molecular genetic analyses of beta-thalassemia in South India reveals rare mutations in the beta-globin gene.

Authors:  Murali Dharan Bashyam; Leena Bashyam; Gorinabele R Savithri; Munimanda Gopikrishna; Vartul Sangal; Akela Radha Rama Devi
Journal:  J Hum Genet       Date:  2004-07-24       Impact factor: 3.172

9.  Determination of the breakpoint and molecular diagnosis of a common alpha-thalassaemia-1 deletion in the Indian population.

Authors:  R V Shaji; S E Eunice; S Baidya; A Srivastava; M Chandy
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

10.  Hemoglobin E distribution in ten endogamous population groups of Assam, India.

Authors:  R Deka; A P Reddy; B N Mukherjee; B M Das; S Banerjee; M Roy; B Dey; K C Malhotra; H Walter
Journal:  Hum Hered       Date:  1988       Impact factor: 0.444

View more
  12 in total

1.  Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study.

Authors:  Deboshree M Bhattacharyya; Ashis Mukhopadhyay; Jayasri Basak
Journal:  Int J Hematol       Date:  2014-02-01       Impact factor: 2.490

2.  The Prevalence Of β-Thalassemia Mutations in South Western Maharashtra.

Authors:  Sandeep B Satpute; Mangesh P Bankar; Abdulrahaman A Momin
Journal:  Indian J Clin Biochem       Date:  2012-06-17

3.  Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major.

Authors:  Aabha Nagral; Smita Sawant; Nishtha Nagral; Pathik Parikh; Priya Malde; Rashid Merchant
Journal:  J Clin Exp Hepatol       Date:  2017-08-23

4.  Prenatal diagnosis of α- and β-thalassemias in southern Thailand.

Authors:  Chamnong Nopparatana; Chawadee Nopparatana; Vannarat Saechan; Sataron Karnchanaopas; Korntip Srewaradachpisal
Journal:  Int J Hematol       Date:  2019-10-28       Impact factor: 2.490

5.  Combination of two rare mutations causes β-thalassaemia in a Bangladeshi patient.

Authors:  Mahdi Muhammad Moosa; Mustak Ibn Ayub; Ama Emran Bashar; Golam Sarwardi; Waqar Khan; Haseena Khan; Sabina Yeasmin
Journal:  Genet Mol Biol       Date:  2011-07-01       Impact factor: 1.771

6.  Is hemoglobin e gene widely spread in the state of madhya pradesh in central India? Evidence from five typical families.

Authors:  R S Balgir
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-09-01       Impact factor: 2.576

7.  High resolution melting curve analysis targeting the HBB gene mutational hot-spot offers a reliable screening approach for all common as well as most of the rare beta-globin gene mutations in Bangladesh.

Authors:  Md Tarikul Islam; Suprovath Kumar Sarkar; Nusrat Sultana; Mst Noorjahan Begum; Golam Sarower Bhuyan; Shezote Talukder; A K M Muraduzzaman; Md Alauddin; Mohammad Sazzadul Islam; Pritha Promita Biswas; Aparna Biswas; Syeda Kashfi Qadri; Tahmina Shirin; Bilquis Banu; Salma Sadya; Manzoor Hussain; Golam Sarwardi; Waqar Ahmed Khan; Mohammad Abdul Mannan; Hossain Uddin Shekhar; Emran Kabir Chowdhury; Abu Ashfaqur Sajib; Sharif Akhteruzzaman; Syed Saleheen Qadri; Firdausi Qadri; Kaiissar Mannoor
Journal:  BMC Genet       Date:  2018-01-02       Impact factor: 2.797

8.  Alpha-globin gene mutation spectrum in patients with microcytic hypochromic anemia from Mazandaran Province, Iran.

Authors:  Seyed Mohammad Bagher Hashemi-Soteh; Hossein Karami; Seyed Saeid Mousavi; Touraj Farazmandfar; Ahmad Tamadoni
Journal:  J Clin Lab Anal       Date:  2019-09-02       Impact factor: 3.124

Review 9.  Molecular genetics of β-thalassemia: A narrative review.

Authors:  Tang-Her Jaing; Tsung-Yen Chang; Shih-Hsiang Chen; Chen-Wei Lin; Yu-Chuan Wen; Chia-Chi Chiu
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

Review 10.  Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).

Authors:  Fareeha Amjad; Tamseel Fatima; Tuba Fayyaz; Muhammad Aslam Khan; Muhammad Imran Qadeer
Journal:  Biomed Rep       Date:  2020-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.